Boehringer Ingelheim: Hypertension trials

The registry lists 122 Hypertension studies with Boehringer Ingelheim as lead sponsor. 1 are open to participants now and 41 have results posted.

Phase 1 1Phase 2 4Phase 3 43Phase 4 26No phase 48(a study in two phases counts in both)

Studies

Page 1 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseRecruitingNCT07064473Phase 3
• To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With HypertensionCompletedNCT03021265Results posted
• 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and HypertensionCompletedNCT02182830Phase 3Results posted
• Add-on to Micamlo BP TrialCompletedNCT01975246Phase 3Results posted
• Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus AmlodipineCompletedNCT01911780Phase 3Results posted
• Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk PatientsCompletedNCT01853839Results posted
• 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT01370005Phase 3Results posted
• Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With HypertensionCompletedNCT01353274Results posted
• Twynsta Study With Lifestyle Modifications in Korean Patients With HypertensionCompletedNCT01316419Results posted
• Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)CompletedNCT01286558Phase 3Results posted
• Telmisartan and Amlodipine Versus Monocomponent TabletsCompletedNCT01278797Phase 1Results posted
• A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination TherapyCompletedNCT01243268Results posted
• Telmisartan 80mg Non-responder TrialCompletedNCT01222520Phase 3Results posted
• Telmisartan+Amlodipine Fixed Dose Combination in HypertensionCompletedNCT01204398Phase 3Results posted
• TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switchCompletedNCT01134393Phase 3Results posted
• Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk PatientsCompletedNCT01108809Results posted
• Additional Effect of A Life Style Program on Antihypertensive Treatment With TelmisartanCompletedNCT01108796Results posted
• An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 MonotherapyCompletedNCT01103960Phase 3Results posted
• Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term UseCompletedNCT01050062Results posted
• An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical PracticeCompletedNCT00982735Results posted
• PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mgCompletedNCT00936208Results posted
• Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe HypertensionCompletedNCT00926289Phase 4Results posted
• Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational StudyCompletedNCT00909038Results posted
• Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive PatientsCompletedNCT00904371Results posted
• An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With HypertensionCompletedNCT00904215Results posted
• Telmisartan Tab HypertensionCompletedNCT00890084Results posted
• TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in BelgiumCompletedNCT00886288Results posted
• Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced PatientsCompletedNCT00879411Results posted
• Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00877929Phase 3Results posted
• Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe HypertensionCompletedNCT00860262Phase 3Results posted
• Telmisartan+HCTZ (Hydrochlorothiazide), HypertensionCompletedNCT00659607Results posted
• J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term ObservationCompletedNCT00659581Results posted
• 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in HypertensionCompletedNCT00624052Phase 3Results posted
• An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose CombinationCompletedNCT00618774Phase 3Results posted
• Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in MulticentersCompletedNCT00615108Results posted
• Open Label Study Telmisartan and Amlodipine in HypertensionCompletedNCT00614380Phase 3Results posted
• Clinical EvaluatioN of TElmisartan-based Antihypertensive RegimenCompletedNCT00613314Results posted
• Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant HypertensionCompletedNCT00558428Phase 3Results posted
• Filtered Trial for Amlodipine Non-responderCompletedNCT00558064Phase 3Results posted
• Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant HypertensionCompletedNCT00553267Phase 3Results posted
• Filtered Trial for Telmisartan 40mg Non-responderCompletedNCT00550953Phase 3Results posted
• Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of HypertensionCompletedNCT00281580Phase 3Results posted
• Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic PracticeWithdrawnNCT03205137
• Efficacy and Safety of Telmisartan and Losartan in Primary HypertensionCompletedNCT02269176Phase 3
• Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)CompletedNCT02262637
• Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)CompletedNCT02262611
• Telmisartan in Mild to Moderate Hypertensive PatientsCompletedNCT02260089Phase 4
• Antihypertensive Medications and the Risk of SepsisCompletedNCT02248896
• Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and HydrochlorothiazideCompletedNCT02248129
• Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential HypertensionCompletedNCT02245464
• Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)CompletedNCT02243566
• TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or OlderCompletedNCT02242877
• Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood PressureCompletedNCT02242864
• Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and PatientsCompletedNCT02242851
• Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With HypertensionCompletedNCT02242838
• Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes MellitusCompletedNCT02242825
• Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate HypertensionTerminatedNCT02242812Phase 4
• A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)CompletedNCT02242396
• Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With HypertensionCompletedNCT02242383
• Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential HypertensionCompletedNCT02242370Phase 4
• Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With HypertensionCompletedNCT02242357
• Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With HypertensionCompletedNCT02242344Phase 2
• Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood PressureCompletedNCT02242331
• Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure MonitoringCompletedNCT02242318Phase 4
• Effect of Caldine® on Renal Function in Balanced HypertensionTerminatedNCT02240641
• Post-Marketing Surveillance Study of Micardis® Plus in Patients With HypertensionCompletedNCT02238275
• Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in HospitalsCompletedNCT02238262
• Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential HypertensionCompletedNCT02235415
• A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive PatientsCompletedNCT02235402Phase 4
• Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT02206659Phase 3
• Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial HypertensionCompletedNCT02202525
• A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200653Phase 4
• A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200640Phase 4
• Pharmacovigilance and Patient Compliance in Hypertensive PatientsCompletedNCT02200575
• Micardis®. Observational Study in Patients With Essential HypertensionCompletedNCT02200094
• Micardis® in Patients With Essential HypertensionCompletedNCT02187705
• Pharmacokinetics of BIBR 277 in Hypertensive PatientsCompletedNCT02187497Phase 2
• BIBR 277 Capsules in Hypertensive Patients With NephropathyCompletedNCT02187484Phase 2
• Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential HypertensionCompletedNCT02183701Phase 3
• Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring HemodialysisCompletedNCT02178306Phase 4
• Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan MonotherapyCompletedNCT02177500Phase 3
• Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate HypertensionCompletedNCT02177487Phase 3
• Telmisartan Compared With Enalapril in Elderly Patients With Blood HypertensionCompletedNCT02177461Phase 4
• BIBR 277 Capsule in Patients With Essential HypertensionCompletedNCT02177448Phase 3
• Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate HypertensionCompletedNCT02177435Phase 3
• Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate HypertensionCompletedNCT02177422Phase 3
• Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate HypertensionCompletedNCT02177409Phase 3
• MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure MonitoringCompletedNCT02177396Phase 3
• Lacidipine in Medical Practice in Patients With Mild to Moderate Essential HypertensionCompletedNCT02177331Phase 3
• Safety, Tolerability and Efficacy of Micardis® in Patients With Essential HypertensionCompletedNCT02176850
• Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate HypertensionCompletedNCT02176499Phase 3
• Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)CompletedNCT02175355Phase 3
• Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive PatientsCompletedNCT02172586Phase 4
• Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure RiseCompletedNCT00946829
• Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential HypertensionCompletedNCT00638911
• Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesCompletedNCT00539487
• Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With HypertensionCompletedNCT00326768Phase 3
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaCompletedNCT00316095Phase 3
• Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionCompletedNCT00281593Phase 3
• PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT00274638Phase 4